Identification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity

Journal of Immunology

Volumn 187, Issue 1, 2011, Pages 337-349

  Mohammed, Javid P ^a   Fusakio, Michael E ^a   Rainbow, Daniel B ^b   Moule, Carolyn ^b   Fraser, Heather I ^b   Clark, Jan ^b   Todd, John A ^b   Peterson, Laurence B ^c,g   Savage, Paul B ^d   Wills Karp, Marsha ^a   Ridgway, William M ^e   Wicker, Linda S ^b   Mattner, Jochen ^a,f  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Brigham Young University   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

^f UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^g HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17;

ALPHAPROTEOBACTERIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL CLEARANCE; BACTERIAL INFECTION; BACTERIAL STRAIN; CD101 GENE; CELLULAR IMMUNITY; CHROMOSOME 3; CONTROLLED STUDY; DENDRITIC CELL; DISEASE SEVERITY; FEMALE; GENE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GRANULOCYTE; HAPLOTYPE; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; NOVOSPHINGOBIUM AROMATICIVORANS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEPATITIS, AUTOIMMUNE; LIVER CIRRHOSIS, BILIARY; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, TRANSGENIC; SEVERITY OF ILLNESS INDEX; SPHINGOMONADACEAE;

EID: 79960387074     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003525     Document Type: Article

References (85)

1. Rioux, J. D., and A. K. Abbas. 2005. Paths to understanding the genetic basis of autoimmune disease. Nature 435: 584-589.
2. Björses, P., J. Aaltonen, N. Horelli-Kuitunen, M. L. Yaspo, and L. Peltonen. 1998. Gene defect behind APECED: a new clue to autoimmunity. Hum. Mol. Genet. 7: 1547-1553.
3. Walker, L. S., and A. K. Abbas. 2002. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2: 11-19.
4. He, X. S., A. A. Ansari, W. M. Ridgway, R. L. Coppel, and M. E. Gershwin. 2006. New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis. Cell. Immunol. 239: 1-13.
5. Alonso, A., J. Sasin, N. Bottini, I. Friedberg, I. Friedberg, A. Osterman, A. Godzik, T. Hunter, J. Dixon, and T. Mustelin. 2004. Protein tyrosine phosphatases in the human genome. Cell 117: 699-711. (Pubitemid 38748887)
6. Begovich, A. B., V. E. Carlton, L. A. Honigberg, S. J. Schrodi, A. P. Chokkalingam, H. C. Alexander, K. G. Ardlie, Q. Huang, A. M. Smith, J. M. Spoerke, et al. 2004. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75: 330-337.
7. Kyogoku, C., C. D. Langefeld, W. A. Ortmann, A. Lee, S. Selby, V. E. Carlton, M. Chang, P. Ramos, E. C. Baechler, F. M. Batliwalla, et al. 2004. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet. 75: 504-507.
8. Orozco, G., E. Sánchez, M. A. González-Gay, M. A. López-Nevot, B. Torres, R. Cáliz, N. Ortego-Centeno, J. Jiménez-Alonso, D. Pascual-Salcedo, A. Balsa, et al. 2005. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 52: 219-224. (Pubitemid 40129251)
9. Rose, N. R., A. M. Saboori, L. Rasooly, and C. L. Burek. 1997. The role of iodine in autoimmune thyroiditis. Crit. Rev. Immunol. 17: 511-517.
10. Maier, L. M., C. E. Lowe, J. Cooper, K. Downes, D. E. Anderson, C. Severson, P. M. Clark, B. Healy, N. Walker, C. Aubin, et al; International Multiple Sclerosis Genetics Consortium. 2009. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet. 5: e1000322.
11. Braley-Mullen, H., G. C. Sharp, B. Medling, and H. Tang. 1999. Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J. Autoimmun. 12: 157-165. (Pubitemid 29223047)
12. Rasooly, L., C. L. Burek, and N. R. Rose. 1996. Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin. Immunol. Immunopathol. 81: 287-292.
13. Vladutiu, A. O., and N. R. Rose. 1971. Autoimmune murine thyroiditis relation to histocompatibility (H-2) type. Science 174: 1137-1139.
14. Cooke, A. 2009. Infection and autoimmunity. Blood Cells Mol. Dis. 42: 105-107.
15. Willcocks, L. C., K. G. Smith, and M. R. Clatworthy. 2009. Low-affinity Fcgamma receptors, autoimmunity and infection. Expert Rev. Mol. Med. 11: e24.
16. Bach, J. F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347: 911-920.
17. Kaplan, M. M., and M. E. Gershwin. 2005. Primary biliary cirrhosis. N. Engl. J. Med. 353: 1261-1273.
18. Gershwin, M. E., A. A. Ansari, I. R. Mackay, Y. Nakanuma, A. Nishio, M. J. Rowley, and R. L. Coppel. 2000. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol. Rev. 174: 210-225.
19. Lan, R. Y., T. L. Salunga, K. Tsuneyama, Z. X. Lian, G. X. Yang, W. Hsu, Y. Moritoki, A. A. Ansari, C. Kemper, J. Price, et al. 2009. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J. Autoimmun. 32: 43-51.
20. Honda, M., H. Kawai, Y. Shirota, T. Yamashita, and S. Kaneko. 2005. Differential gene expression profiles in stage I primary biliary cirrhosis. Am. J. Gastroenterol. 100: 2019-2030.
21. Baba, N., H. Kobashi, K. Yamamoto, R. Terada, T. Suzuki, T. Hakoda, N. Okano, N. Shimada, S. Fujioka, Y. Iwasaki, and Y. Shiratori. 2006. Gene expression profiling in biliary epithelial cells of primary biliary cirrhosis using laser capture microdissection and cDNA microarray. Transl. Res. 148: 103-113.
22. Shackel, N. A., P. H. McGuinness, C. A. Abbott, M. D. Gorrell, and G. W. McCaughan. 2001. Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut 49: 565-576.
23. Harada, K., and Y. Nakanuma. 2007. Biliary innate immunity and cholangiopathy. Hepatol. Res. 37(Suppl 3): S430-S437.
24. Harada, K., K. Isse, T. Kamihira, S. Shimoda, and Y. Nakanuma. 2005. Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis. Hepatology 41: 1329-1338. (Pubitemid 40770286)
25. Morishita, A., M. Murota, J. Fujita, Y. Ohtsuki, and M. Nishioka. 2001. Helper T lymphocytes specific for cytokeratin 19 in patients with primary biliary cirrhosis. Hepatol. Res. 21: 108-116.
26. Nagano, T., K. Yamamoto, S. Matsumoto, R. Okamoto, M. Tagashira, N. Ibuki, S. Matsumura, K. Yabushita, N. Okano, and T. Tsuji. 1999. Cytokine profile in the liver of primary biliary cirrhosis. J. Clin. Immunol. 19: 422-427.
27. Pisetsky, D. S. 2008. The role of innate immunity in the induction of autoimmunity. Autoimmun. Rev. 8: 69-72.
28. Bergman, M., G. Del Prete, Y. van Kooyk, and B. Appelmelk. 2006. Helicobacter pylori phase variation, immune modulation and gastric autoimmunity. Nat. Rev. Microbiol. 4: 151-159.
29. Benoist, C., and D. Mathis. 2001. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat. Immunol. 2: 797-801.
30. Marshak-Rothstein, A., and I. R. Rifkin. 2007. Immunologically active auto-antigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu. Rev. Immunol. 25: 419-441.
31. Lunardi, C., E. Tinazzi, C. Bason, M. Dolcino, R. Corrocher, and A. Puccetti. 2008. Human parvovirus B19 infection and autoimmunity. Autoimmun. Rev. 8: 116-120.
32. Holmøy, T., and A. L. Hestvik. 2008. Multiple sclerosis: immunopathogenesis and controversies in defining the cause. Curr. Opin. Infect. Dis. 21: 271-278.
33. Niller, H. H., H. Wolf, and J. Minarovits. 2008. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity 41: 298-328. (Pubitemid 351593860)
34. Bach, J. F. 2005. Infections and autoimmune diseases. J. Autoimmun. 25(Suppl): 74-80.
35. Neisser, A., B. Schwerer, H. Bernheimer, and A. P. Moran. 2000. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome. J. Neuroimmunol. 102: 85-88.
36. Yuki, N., K. Susuki, M. Koga, Y. Nishimoto, M. Odaka, K. Hirata, K. Taguchi, T. Miyatake, K. Furukawa, T. Kobata, and M. Yamada. 2004. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc. Natl. Acad. Sci. USA 101: 11404-11409.
37. Selmi, C., D. L. Balkwill, P. Invernizzi, A. A. Ansari, R. L. Coppel, M. Podda, P. S. Leung, T. P. Kenny, J. Van De Water, M. H. Nantz, et al. 2003. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 38: 1250-1257. (Pubitemid 37314834)
38. Kaplan, M. M. 2004. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am. J. Gastroenterol. 99: 2147-2149.
39. Padgett, K. A., C. Selmi, T. P. Kenny, P. S. Leung, D. L. Balkwill, A. A. Ansari, R. L. Coppel, and M. E. Gershwin. 2005. Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis. J. Autoimmun. 24: 209-219.
40. Bogdanos, D. P., and D. Vergani. 2009. Bacteria and primary biliary cirrhosis. Clin. Rev. Allergy Immunol. 36: 30-39.
41. Olafsson, S., H. Gudjonsson, C. Selmi, K. Amano, P. Invernizzi, M. Podda, and M. E. Gershwin. 2004. Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives. Am. J. Gastroenterol. 99: 2143-2146.
42. Mattner, J., P. B. Savage, P. Leung, S. S. Oertelt, V.Wang, O. Trivedi, S. T. Scanlon, K. Pendem, L. Teyton, J. Hart, et al. 2008. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 3: 304-315. (Pubitemid 351637431)
43. Maier, L. M., D. J. Smyth, A. Vella, F. Payne, J. D. Cooper, R. Pask, C. Lowe, J. Hulme, L. J. Smink, H. Fraser, et al. 2005. Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetes. BMC Genet. 6: 9.
44. Penha-Gonçalves, C., C. Moule, L. J. Smink, J. Howson, S. Gregory, J. Rogers, P. A. Lyons, J. J. Suttie, C. J. Lord, L. B. Peterson, et al. 2003. Identification of a structurally distinct CD101 molecule encoded in the 950-kb Idd10 region of NOD mice. Diabetes 52: 1551-1556. (Pubitemid 36666213)
45. Podolin, P. L., P. Denny, C. J. Lord, N. J. Hill, J. A. Todd, L. B. Peterson, L. S. Wicker, and P. A. Lyons. 1997. Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1. J. Immunol. 159: 1835-1843.
46. Yamaji, K., H. Ikegami, T. Fujisawa, S. Noso, K. Nojima, N. Babaya, M. Itoi-Babaya, S. Makino, T. Sakamoto, and T. Ogihara. 2005. Evidence for Cd101 but not Fcgr1 as candidate for type 1 diabetes locus, Idd10. Biochem. Biophys. Res. Commun. 331: 536-542.
47. Rainbow, D. B., C. Moule, H. I. Fraser, J. Clark, S. K. Howlett, O. Burren, M. Christensen, V. Moody, C. A. Steward, J. P. Mohammed, et al. 2011. Evidence that Cd101 is an autoimmune diabetes gene in nonobese diabetic mice. J. Immunol. 187: 325-336.
48. Hamilton-Williams, E. E., X. Martinez, J. Clark, S. Howlett, K. M. Hunter, D. B. Rainbow, L. Wen, M. J. Shlomchik, J. D. Katz, G. F. Beilhack, et al. 2009. Expression of diabetes-associated genes by dendritic cells and CD4 T cells drives the loss of tolerance in nonobese diabetic mice. J. Immunol. 183: 1533-1541.
49. Fraser, H. I., C. A. Dendrou, B. Healy, D. B. Rainbow, S. Howlett, L. J. Smink, S. Gregory, C. A. Steward, J. A. Todd, L. B. Peterson, and L. S. Wicker. 2010. Nonobese diabetic congenic strain analysis of autoimmune diabetes reveals genetic complexity of the Idd18 locus and identifies Vav3 as a candidate gene. J. Immunol. 184: 5075-5084.
50. Podolin, P. L., P. Denny, N. Armitage, C. J. Lord, N. J. Hill, E. R. Levy, L. B. Peterson, J. A. Todd, L. S. Wicker, and P. A. Lyons. 1998. Localization of two insulin-dependent diabetes (Idd) genes to the Idd10 region on mouse chromosome 3. Mamm. Genome 9: 283-286.
51. Mattner, J., K. L. Debord, N. Ismail, R. D. Goff, C. Cantu, III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529. (Pubitemid 40477062)
52. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Bendelac. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191: 1895-1903.
53. Fernandez, I., R. Zeiser, H. Karsunky, N. Kambham, A. Beilhack, K. Soderstrom, R. S. Negrin, and E. Engleman. 2007. CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells. J. Immunol. 179: 2808-2814.
54. Bonacchi, A., I. Petrai, R. M. Defranco, E. Lazzeri, F. Annunziato, E. Efsen, L. Cosmi, P. Romagnani, S. Milani, P. Failli, et al. 2003. The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 125: 1060-1076. (Pubitemid 37193453)
55. Borchers, A. T., S. Shimoda, C. Bowlus, C. L. Keen, and M. E. Gershwin. 2009. Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Semin. Immunopathol. 31: 309-322.
56. Santodomingo-Garzon, T., J. Han, T. Le, Y. Yang, and M. G. Swain. 2009. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice. Hepatology 49: 1267-1276.
57. Ruegg, C. L., A. Rivas, N. D. Madani, J. Zeitung, R. Laus, and E. G. Engleman. 1995. V7, a novel leukocyte surface protein that participates in T cell activation. II. Molecular cloning and characterization of the V7 gene. J. Immunol. 154: 4434-4443.
58. Bouloc, A., M. Bagot, S. Delaire, A. Bensussan, and L. Boumsell. 2000. Triggering CD101 molecule on human cutaneous dendritic cells inhibits T cell proliferation via IL-10 production. Eur. J. Immunol. 30: 3132-3139.
59. Bouloc, A., M. L. Boulland, F. Geissmann, S. Fraitag, P. Andry, D. Teillac, A. Bensussan, J. Revuz, L. Boumsell, J. Wechsler, and M. Bagot. 2000. CD101 expression by Langerhans cell histiocytosis cells. Histopathology 36: 229-232. (Pubitemid 30145249)
60. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
61. Brigl, M., and M. B. Brenner. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22: 817-890.
62. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900.
63. Van Kaer, L. 2007. NKT cells: T lymphocytes with innate effector functions. Curr. Opin. Immunol. 19: 354-364.
64. Soares, L. R., L. Tsavaler, A. Rivas, and E. G. Engleman. 1998. V7 (CD101) ligation inhibits TCR/CD3-induced IL-2 production by blocking Ca2+ flux and nuclear factor of activated T cell nuclear translocation. J. Immunol. 161: 209-217.
65. Shao, L., A. R. Jacobs, V. V. Johnson, and L. Mayer. 2005. Activation of CD8+ regulatory T cells by human placental trophoblasts. J. Immunol. 174: 7539-7547.
66. Manolio, T. A., L. D. Brooks, and F. S. Collins. 2008. A HapMap harvest of insights into the genetics of common disease. J. Clin. Invest. 118: 1590-1605.
67. Hirschhorn, J. N. 2009. Genomewide association studies - illuminating biologic pathways. N. Engl. J. Med. 360: 1699-1701.
68. Hirschhorn, J. N., and M. J. Daly. 2005. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6: 95-108.
69. Maier, L. M., and L. S. Wicker. 2005. Genetic susceptibility to type 1 diabetes. Curr. Opin. Immunol. 17: 601-608.
70. Hirschfield, G. M., X. Liu, C. Xu, Y. Lu, G. Xie, Y. Lu, X. Gu, E. J. Walker, K. Jing, B. D. Juran, et al. 2009. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N. Engl. J. Med. 360: 2544-2555.
71. Liu, X., P. Invernizzi, Y. Lu, R. Kosoy, Y. Lu, I. Bianchi, M. Podda, C. Xu, G. Xie, F. Macciardi, et al. 2010. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat. Genet. 42: 658-660.
72. Hirschfield, G. M., X. Liu, Y. Han, I. P. Gorlov, Y. Lu, C. Xu, Y. Lu, W. Chen, B. D. Juran, C. Coltescu, et al. 2010. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat. Genet. 42: 655-657.
73. Rivas, A., C. L. Ruegg, J. Zeitung, R. Laus, R. Warnke, C. Benike, and E. G. Engleman. 1995. V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies. J. Immunol. 154: 4423-4433.
74. Soares, L. R., A. Rivas, L. Tsavaler, and E. G. Engleman. 1997. Ligation of the V7 molecule on T cells blocks anergy induction through a CD28-independent mechanism. J. Immunol. 159: 1115-1124.
75. Grant, A. J., S. Goddard, J. Ahmed-Choudhury, G. Reynolds, D. G. Jackson, M. Briskin, L. Wu, S. G. Hübscher, and D. H. Adams. 2002. Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am. J. Pathol. 160: 1445-1455.
76. Yoneyama, H., and T. Ichida. 2005. Recruitment of dendritic cells to pathological niches in inflamed liver. Med. Mol. Morphol. 38: 136-141.
77. Sica, G. L., I. H. Choi, G. Zhu, K. Tamada, S. D. Wang, H. Tamura, A. I. Chapoval, D. B. Flies, J. Bajorath, and L. Chen. 2003. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 18: 849-861. (Pubitemid 36776432)
78. Suh, W. K., S. Wang, G. S. Duncan, Y. Miyazaki, E. Cates, T. Walker, B. U. Gajewska, E. Deenick, W. Dawicki, H. Okada, et al. 2006. Generation and characterization of B7-H4/B7S1/B7x-deficient mice. Mol. Cell. Biol. 26: 6403-6411.
79. Zhu, G., M. M. Augustine, T. Azuma, L. Luo, S. Yao, S. Anand, A. C. Rietz, J. Huang, H. Xu, A. S. Flies, et al. 2009. B7-H4-deficient mice display augmented neutrophil-mediated innate immunity. Blood 113: 1759-1767.
80. Chen, Y., C. Yang, Z. Xie, L. Zou, Z. Ruan, X. Zhang, Y. Tang, L. Fei, Z. Jia, and Y. Wu. 2006. Expression of the novel co-stimulatory molecule B7-H4 by renal tubular epithelial cells. Kidney Int. 70: 2092-2099. (Pubitemid 44871371)
81. You, S., B. Leforban, C. Garcia, J. F. Bach, J. A. Bluestone, and L. Chatenoud. 2007. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc. Natl. Acad. Sci. USA 104: 6335-6340.
82. You, S., M. Belghith, S. Cobbold, M. A. Alyanakian, C. Gouarin, S. Barriot, C. Garcia, H. Waldmann, J. F. Bach, and L. Chatenoud. 2005. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 54: 1415-1422. (Pubitemid 40586672)
83. Herbelin, A., J. M. Gombert, F. Lepault, J. F. Bach, and L. Chatenoud. 1998. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse. J. Immunol. 161: 2620-2628.
84. Billiard, F., E. Litvinova, D. Saadoun, F. Djelti, D. Klatzmann, J. L. Cohen, G. Marodon, and B. L. Salomon. 2006. Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation. J. Immunol. 177: 2167-2174.
85. Salomon, B., D. J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J. A. Bluestone. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.